3ufy
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3ufy.jpg|left|200px]] | ||
| - | |||
{{STRUCTURE_3ufy| PDB=3ufy | SCENE= }} | {{STRUCTURE_3ufy| PDB=3ufy | SCENE= }} | ||
| - | |||
===AKR1C3 complex with R-naproxen=== | ===AKR1C3 complex with R-naproxen=== | ||
| + | {{ABSTRACT_PUBMED_22937138}} | ||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/AK1C3_HUMAN AK1C3_HUMAN]] Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone. | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3ufy]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | [[3ufy]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3UFY OCA]. |
| - | [[Category: | + | |
| + | ==See Also== | ||
| + | *[[Prostaglandin F synthase|Prostaglandin F synthase]] | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:022937138</ref><references group="xtra"/><references/> | ||
| + | [[Category: Human]] | ||
[[Category: Chai, M.]] | [[Category: Chai, M.]] | ||
[[Category: Flanagan, J U.]] | [[Category: Flanagan, J U.]] | ||
Revision as of 06:37, 26 March 2014
Contents |
AKR1C3 complex with R-naproxen
Template:ABSTRACT PUBMED 22937138
Function
[AK1C3_HUMAN] Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone.
About this Structure
3ufy is a 1 chain structure with sequence from Human. Full crystallographic information is available from OCA.
See Also
Reference
- Flanagan JU, Yosaatmadja Y, Teague RM, Chai MZ, Turnbull AP, Squire CJ. Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3. PLoS One. 2012;7(8):e43965. doi: 10.1371/journal.pone.0043965. Epub 2012 Aug 28. PMID:22937138 doi:http://dx.doi.org/10.1371/journal.pone.0043965
